Sera of patients with systemic lupus erythematosus react with plasmodial antigens and can inhibit the in vitro growth of Plasmodium falciparum

References

• Daniel-Ribeiro CT, Zanini G. Autoimmunity and malaria: What are they doing together?. Acta Trop. 2000; 76205–221.
   PubMedGoogle Scholar
• Abu-Shakra M, Shoenfeld Y. Parasitic infection and autoimmunity. Autoimmunity. 1991; 9337–344.
   PubMed Web of Science ®Google Scholar
• Yoder BJ, Goodrum KJ. Plasmodium chabaudi chabaudi: B-1 cell expansion correlates with semiresistance in balb/cj mice. Exp Parasitol. 2001; 9871–82.
   PubMedGoogle Scholar
• Greenwood BM. Autoimmune disease and parasitic infections in nigerians. Lancet. 1968; 2380–382.
   PubMed Web of Science ®Google Scholar
• Butcher GA. Sarcoidosis and malaria. Immunol Today. 1995; 16252–253.
   PubMedGoogle Scholar
• McNicol MWSarcoidosisEthnic factors in health and diseaseCruickshank JKBeeLer DGWrightLondon1989209–215.
   Google Scholar
• Sotgiu S, Angius A, Embry A, Rosati G, Musumeci S. Hygiene hypothesis: Innate immunity, malaria and multiple sclerosis. Med Hypotheses. 2008; 70819–825.
   PubMed Web of Science ®Google Scholar
• Zaccone P, Burton OT, Cooke A. Interplay of parasite-driven immune responses and autoimmunity. Trends Parasitol. 2008; 2435–42.
   PubMedGoogle Scholar
• Bate CA, Taverne J, Roman E, Moreno C, Playfair JH. Tumour necrosis factor induction by malaria exoantigens depends upon phospholipid. Immunology. 1992; 75129–135.
   PubMed Web of Science ®Google Scholar
• Souza-Passos LF. Apoptosis and SLE: Another piece in the puzzle?. Rev Bras Reumatol. 1997; 37327–334.
   Google Scholar
• Dighiero G. Natural autoantibodies, tolerance, and autoimmunity. Ann N Y Acad Sci. 1997; 815182–192.
   PubMedGoogle Scholar
• Butcher GA. Malaria and macrophage function in africans: A possible link with autoimmune disease?. Med Hypotheses. 1996; 4797–100.
   PubMedGoogle Scholar
• Butcher G. Autoimmunity and malaria. Trends Parasitol. 2008; 24291–292.
   PubMedGoogle Scholar
• Perignon JL, Druilhe P. Immune mechanisms underlying the premunition against plasmodium falciparum malaria. Mem Inst Oswaldo Cruz. 1994; 89 Suppl 251–53.
   PubMedGoogle Scholar
• Jayawardena AN, Janeway CAJr, Kemp JD. Experimental malaria in the cba/n mouse. J Immunol. 1979; 1232532–2539.
   PubMed Web of Science ®Google Scholar
• Jarra W. Protective immunity to malaria and anti-erythrocyte autoimmunity. Ciba Found Symp. 1983; 94137–158.
   PubMedGoogle Scholar
• Daniel-Ribeiro CT. Is there a role for autoimmunity in immune protection against malaria?. Mem Inst Oswaldo Cruz. 2000; 95199–207.
   PubMedGoogle Scholar
• Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI, a disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum. 1992; 35630–640.
   PubMed Web of Science ®Google Scholar
• Ferreira AW, Sanches MCA. Malária humana. Padronização e optimização de testes sorológicos para diagnóstico individual e inquéritos soroepidemiológicos. Rev Inst Med Trop São Paulo. 1988; 30137–146.
   PubMedGoogle Scholar
• Trager W, Jensen JB. Human malaria parasites in continuous culture. Science. 1976; 193673–675.
   PubMed Web of Science ®Google Scholar
• Coen H, Pauwels M, Roels F. The rat liver cell nuclear imprint as a standard for DNA measurements. Anal Cell Pathol. 1992; 4273–285.
   PubMedGoogle Scholar
• Aarden LA, de Groot ER, Feltkamp TE. Immunology of DNA. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique. Ann N Y Acad Sci. 1975; 254505–515.
   PubMed Web of Science ®Google Scholar
• Balthazar-Guedes HC, Ferreira-Da-Cruz MF, Montenegro-James S, Daniel-Ribeiro CT. Malaria diagnosis. Identification of an anti-40-kda polypeptide antibody response associated with active or recent infection and study of the igg/igm ratio of antibodies to blood-stage plasmodium falciparum antigens. Parasitol Res. 1995; 81305–309.
   PubMedGoogle Scholar
• Banic DM, de Oliveira-Ferreira J, Pratt-Riccio LR, Conseil V, Goncalves D, Fialho RR, Gras-Masse H, Daniel-Ribeiro CT, Camus D. Immune response and lack of immune response to plasmodium falciparum p126 antigen and its amino-terminal repeat in malaria-infected humans. Am J Trop Med Hyg. 1998; 58768–774.
   PubMedGoogle Scholar
• James MA, Montenegro-James S, Fajfar-Whetstone C. Immunogenicity and antigenic reactivity of a carrier-free synthetic peptide complex derived from a 70-kda plasmodium falciparum exoantigen. Parasitol Res. 1993; 79501–507.
   PubMedGoogle Scholar
• Druilhe P, Puebla RM, Miltgen F, Perrin L, Gentilini M. Species- and stage-specific antigens in exoerythrocytic stages of plasmodium falciparum. Am J Trop Med Hyg. 1984; 33336–341.
   PubMed Web of Science ®Google Scholar
• Carvalho LJ, Oliveira SG, Theisen M, Alves FA, Andrade MC, Zanini GM, Brigido MC, Oeuvray C, Povoa MM, Muniz JA, Druilhe P, Daniel-Ribeiro CT. Immunization of saimiri sciureus monkeys with plasmodium falciparum merozoite surface protein-3 and glutamate-rich protein suggests that protection is related to antibody levels. Scand J Immunol. 2004; 59363–372.
   PubMed Web of Science ®Google Scholar
• Perlmann H, Perlmann P, Berzins K, Wahlin B, Troye-Blomberg M, Hagstedt M, Andersson I, Hogh B, Petersen E, Bjorkman A. Dissection of the human antibody response to the malaria antigen pf155/resa into epitope specific components. Immunol Rev. 1989; 112115–132.
   PubMed Web of Science ®Google Scholar
• Dziegiel M, Borre MB, Jepsen S, Hogh B, Petersen E, Vuust J. Recombinant plasmodium falciparum glutamate rich protein; purification and use in enzyme-linked immunosorbent assay. Am J Trop Med Hyg. 1991; 44306–313.
   PubMedGoogle Scholar
• Lopez JA, Roggero MA, Duombo O, Gonzalez JM, Tolle R, Koita O, Arevalo-Herrera M, Herrera S, Corradin G. Recognition of synthetic 104-mer and 102-mer peptides corresponding to n- and c-terminal nonrepeat regions of the plasmodium falciparum circumsporozoite protein by sera from human donors. Am J Trop Med Hyg. 1996; 55424–429.
   PubMed Web of Science ®Google Scholar
• de Oliveira CI, Wunderlich G, Levitus G, Soares IS, Rodrigues MM, Tsuji M, del Portillo HA. Antigenic properties of the merozoite surface protein 1 gene of plasmodium vivax. Vaccine. 1999; 172959–2968.
   PubMedGoogle Scholar
• Lambros C, Vanderberg JP. Synchronization of plasmodium falciparum erythrocytic stages in culture. J Parasitol. 1979; 65418–420.
   PubMed Web of Science ®Google Scholar
• Cunha-Neto E, Iwai LK, Bilate AM, Fonseca SG, Kalil JAutoimmunity in Chagas diseaseInfection and autoimmunityShoenfeld YRose NElsevierAmsterdam2004451–468.
   Google Scholar
• Rizzo LV, Cunha-Neto E, Teixeira AR. Autoimmunity in Chagas' disease: Specific inhibition of reactivity of CD4+t cells against myosin in mice chronically infected with Trypanosoma cruzi. Infect Immun. 1989; 572640–2644.
   PubMedGoogle Scholar
• Iwai LK, Juliano MA, Juliano L, Kalil J, Cunha-Neto E. T-cell molecular mimicry in chagas disease: Identification and partial structural analysis of multiple cross-reactive epitopes between trypanosoma cruzi b13 and cardiac myosin heavy chain. J Autoimmun. 2005; 24111–117.
   PubMedGoogle Scholar
• Tadokoro CE, Vallochi AL, Rios LS, Martins GA, Schlesinger D, Mosca T, Kuchroo VK, Rizzo LV, Abrahamsohn IA. Experimental autoimmune encephalomyelitis can be prevented and cured by infection with Trypanosoma cruzi. J Autoimmun. 2004; 23103–115.
   PubMedGoogle Scholar
• Greenwood BM, Herrick EM, Voller A. Suppression of autoimmune disease in nzb and (nzb × nzw) f1 hybrid mice by infection with malaria. Nature. 1970; 226266–267.
   PubMedGoogle Scholar
• Hentati B, Sato MN, Payelle-Brogard B, Avrameas S, Ternynck T. Beneficial effect of polyclonal immunoglobulins from malaria-infected balb/c mice on the lupus-like syndrome of (nzb × nzw)f1 mice. Eur J Immunol. 1994; 248–15.
   PubMedGoogle Scholar
• Berlin T, Zandman-Goddart G, Blank M, Matthias T, Pfeiffer S, Weiss I, Toubi E, Singh S, Asherson R, Frazer A, Gilburd B, Sapir T, Levy Y, Lukac J, Rozman B, Kveder T, Shoenfeld Y. Autoantibodies in nonautoimmune individuals during infections. Ann N Y Acad Sci. 2007; 1108584–593.
   PubMed Web of Science ®Google Scholar
• Arvieux J, Renaudineau Y, Mane I, Perraut R, Krilis SA, Youinou P. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome. Thromb Haemost. 2002; 87599–605.
   PubMed Web of Science ®Google Scholar
• Dugué C, Perraut C, Youinou P, Renaudineau Y. Effects of anti-endothelial cell antibodies in leprosy and malaria. Infect Immun. 2004; 72301–309.
   PubMedGoogle Scholar
• Milner ECB, Anolik J, Cappione A, Sanz I. Human innate B cells: A link between host defense and autoimmunity?. Springer Semin Immun. 2005; 26433–452.
   PubMed Web of Science ®Google Scholar
• Baker VS, Imade GE, Molta NB, Tawde P, Pam SD, Obadofin MO, Sagay SA, Egah DZ, Iya D, Afolabi BB, Baker M, Ford K, Ford R, Roux KH, Keller TCIII. Cytokine-associated neutrophil extracellular traps and antinuclear antibodies in plasmodium falciparum infected children under six years of age. Malar J. 2008; 741.
   PubMed Web of Science ®Google Scholar
• Consigny PH, Cauquelin B, Agnamey P, Comby E, Brasseur P, Ballet JJ, Roussilhon C. High prevalence of co-factor independent anticardiolipin antibodies in malaria exposed individuals. Clin Exp Immunol. 2002; 127158–164.
   PubMedGoogle Scholar
• Daniel-Ribeiro C, Kalil J, Monjour L, Alfred C, Ploton I, Gentilini M. Cross reactions between plasmodium falciparum and mammalian tissue antigens detected by monoclonal antibodies. Ann Trop Med Parasitol. 1984; 7875–76.
   PubMedGoogle Scholar
• Oldstone MB. Molecular mimicry, microbial infection, and autoimmune disease: Evolution of the concept. Curr Top Microbiol Immunol. 2005; 2961–17.
   PubMed Web of Science ®Google Scholar
• Karlsen AE, Dyrberg T. Molecular mimicry between non-self, modified self and self in autoimmunity. Semin Immunol. 1998; 1025–34.
   PubMedGoogle Scholar
• Du H, Chen M, Zhang Y, Zhao MH, Wang HY. Cross-reaction of anti-DNA autoantibodies with membrane proteins of human glomerular mesangial cells in sera from patients with lupus nephritis. Clin Exp Immunol. 2006; 14521–27.
   PubMed Web of Science ®Google Scholar
• Eilat D, Zlotnick AY, Fischel R. Evaluation of the cross-reaction between anti-DNA and anti-cardiolipin antibodies in SLE and experimental animals. Clin Exp Immunol. 1986; 65269–278.
   PubMed Web of Science ®Google Scholar
• Maguire PA, Prudhomme J, Sherman IW. Alterations in erythrocyte membrane phospholipid organization due to the intracellular growth of the human malaria parasite, plasmodium falciparum. Parasitology. 1991; 102179–186.
   PubMedGoogle Scholar
• Singh S, Chatterjee S, Sohoni R, Badakere S, Sharma S. Sera from lupus patients inhibit growth of P falciparum in culture. Autoimmunity. 2001; 33253–263.
   PubMed Web of Science ®Google Scholar
• Carvalho LJ, Daniel-Ribeiro CT, Goto H. Malaria vaccine: Candidate antigens, mechanisms, constraints and prospects. Scand J Immunol. 2002; 56327–343.
   PubMedGoogle Scholar
• Langhorne J, Ndungu FM, Sponaas AM, Marsh K. Immunity to malaria: More questions than answers. Nat Immunol. 2008; 9725–732.
   PubMed Web of Science ®Google Scholar